Search
Learn about
Our Products
Ecosystems
Portfolios
Due Diligence
Funder Prospecting
Log in
Start
for Free
HARRINGTON CANCER AND HEALTH FOUNDATION
Sign up to claim this org
HARRINGTON CANCER AND HEALTH FOUNDATION
Amarillo, TX, US
•
501(c)3
•
EIN
75-1578415
•
WWW.HCHFAMARILLO.ORG
•
Regional Funder
HARRINGTON CANCER AND HEALTH FOUNDATION
Sign up to claim this org
Amarillo, TX, US
•
501(c)3
•
EIN
75-1578415
•
WWW.HCHFAMARILLO.ORG
•
Regional Funder
Overview
Programs
990s
Income Statement
Balance Sheet
How to Apply
Sign up
for more:
People
Board & Team
Financials
Financial Trends
Funding
Funders
Grants Received
Grantmaking
Giving Insights
Grantees
Grants Given
Overlap
Hide details
Income Statement
Fiscal Year Start:
Jan 1
Revenues in
2024
$7,674,394
Other
55%
Fundraising Events
18%
Investments
15%
Contributions
8%
Program Services
5%
Government Grants
0%
Membership Dues
0%
Expenses in
2024
$5,016,570
Grants
47%
Salaries & Benefits
21%
Other
15%
Fees to Service Providers
12%
Offices, Occupancy & IT
3%
Advertising & Promotion
<1%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$1,185,038
$621,779
-48%
Government Grants
$0
$0
-
Fundraising Events
$839,513
$1,359,302
+62%
Program Services
$540,292
$374,812
-31%
Membership Dues
$0
$0
-
Investments
$1,120,444
$1,113,458
-1%
Other
$3,982,688
$4,205,043
+6%
Total Revenues
$7,667,975
$7,674,394
+0%
Expenses
2023
2024
Change
Grants
$2,442,692
$2,372,097
-3%
Benefits to Members
$0
$0
-
Salaries & Benefits
$1,007,117
$1,064,025
+6%
Fees to Service Providers
$575,815
$602,838
+5%
Advertising & Promotion
$22,622
$34,517
+53%
Offices, Occupancy & IT
$179,014
$167,862
-6%
Interest
$0
$0
-
Depreciation
$3,710
$7,431
+100%
Other
$566,186
$767,800
+36%
Total Expenses
$4,797,156
$5,016,570
+5%
Net income
2023
2024
Change
Net income
+$2,870,819
+$2,657,824
-7%
Functional Expenses
Summary
2023
2024
Change
Program
$3,466,465
$3,620,649
+4%
Admin
$759,911
$814,066
+7%
Fundraising
$570,780
$581,855
+2%
Total Expenses
$4,797,156
$5,016,570
+5%
Income Statement
